expanding hla typing requirements (resolution 10) histocompatibility committee dolly tyan, phd chair
TRANSCRIPT
![Page 1: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/1.jpg)
Expanding HLA Typing Requirements
(Resolution 10)
Histocompatibility CommitteeDolly Tyan, PhD Chair
![Page 2: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/2.jpg)
Strategic Plan
![Page 3: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/3.jpg)
New KAS takes effect in December
Candidates with CPRA greater than 98% will receive regional and national priority before all other kidney candidates
Literature shows a significant number of sensitized candidates have antibodies to HLA-DQA/DPB
There are currently no fields in DonorNet® to report these HLA types on donors or in Waitlist℠ as unacceptable antigens for candidates
Without this information, there is a high risk for discards and increased CIT in KAS
The Problem
![Page 4: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/4.jpg)
Sequence AKDPI <=20%
Sequence BKDPI >20% but
<35%
Sequence CKDPI >=35% but
<=85%
Sequence DKDPI>85%
Highly Sensitized0-ABDRmm (top 20% EPTS)Prior living donorLocal pediatricsLocal top 20% EPTS0-ABDRmm (all)Local (all)Regional pediatricsRegional (top 20%)Regional (all)National pediatricsNational (top 20%)National (all)
Highly Sensitized0-ABDRmmPrior living donorLocal pediatricsLocal adultsRegional pediatricsRegional adultsNational pediatricsNational adults
Highly Sensitized0-ABDRmmPrior living donorLocal RegionalNational
Highly Sensitized0-ABDRmmLocal + Regional National
CPRA greater than 98%
![Page 5: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/5.jpg)
Other Problems
![Page 6: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/6.jpg)
HLA DQA and –DPB reported when typing is performed on DD. Program DQA and DPB fields in DonorNet® and Waitlist® as unacceptable antigens
Require consistent and complete list of loci reported on DD
Require molecular methods when performing HLA typing on DD
Align policy requirements for deceased islet donors and candidates with those of pancreas donors and candidates
Proposed Changes
![Page 7: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/7.jpg)
Overall Project Impact
All deceased donors, candidates, and recipients. Special emphasis for highly sensitized candidates and all kidney candidates.
![Page 8: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/8.jpg)
Frequency of DQA/DPB UAs
![Page 9: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/9.jpg)
% of KPD Candidates with HLA-DPB and DQA UAs
N=462
CPRA ValueNote that for kidney waiting list: 84% have CPRA 0-79%, 4% - 80-94%, 5% - 95-99 and 6% - 100%
![Page 10: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/10.jpg)
Two Programming Options
![Page 11: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/11.jpg)
Pro: •Allows deceased donor HLA info to be reported for these types•Slight reduction in IT programming estimate
(still in large category)Con: •Patient safety concerns •Burdensome for transplant programs•Inconsistent with programming for all other HLA reporting and the KPD program•Committees expressed patient safety concerns
![Page 12: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/12.jpg)
Pro: •Eliminates patient safety concerns •Less burdensome to transplant programs•Consistent with KPD programming•Supported by community (based on feedback from regions, Kidney Committee, OPO Committee, Pancreas Committee, Operations and Safety Committee, and ASHI)Con: •Higher IT programming cost (very large category)
![Page 13: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/13.jpg)
Cost-Benefit Analysis
![Page 14: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/14.jpg)
Public Comment/Professional Society Feedback
![Page 15: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/15.jpg)
The Board is asked to approved additions and changes to Policies 2.11.A (Required information for Deceased Kidney Donors); 2.11.B (Required information for Deceased Liver Donors); 2.11.C (Required Information for Deceased Heart Donors); 2.11.D (Required Information for Deceased Lung Donors); 2.11.E (Required Information for Deceased Pancreas Donors); 3.4.D (Candidate Human Leukocyte Antigen (HLA Information); and 4.2 (Requirements for Performing and Reporting HLA Typing) to provide greater consistency in HLA typing requirements across organ types.
*Page 74 of Board book
RESOLUTION 20
![Page 16: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/16.jpg)
Extra Slides
![Page 17: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/17.jpg)
Background
![Page 18: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/18.jpg)
HLA Typing Requirements for Deceased Donors
Organ A B Bw4 Bw6 C DR DR51 DR52 DR53 DPB DQA DQB
Kidney • • • • • • • • • •
Pancreas • • • • • • • • • •
Kidney-Pancreas • • • • • • • • • •
Heart* • • • • • • • •
Lung* • • • • • • • •
Liver
Pancreas Islet *For deceased heart and lung donors, if a transplant hospital requires donor HLA typing prior to submitting a final organ acceptance, it must communicate this request to the OPO and the OPO must provide the HLA information required in the table above and document this request. The transplant hospital may request HLA-DPB typing, but the OPO need only provide it if its affiliated laboratory performs related testing.
![Page 19: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/19.jpg)
![Page 20: Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair](https://reader036.vdocument.in/reader036/viewer/2022062518/56649f435503460f94c62f8f/html5/thumbnails/20.jpg)
Supporting Evidence DPB Typed Deceased Donors